0000899243-21-025758.txt : 20210624
0000899243-21-025758.hdr.sgml : 20210624
20210624173243
ACCESSION NUMBER: 0000899243-21-025758
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210624
FILED AS OF DATE: 20210624
DATE AS OF CHANGE: 20210624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sulzberger Gabrielle
CENTRAL INDEX KEY: 0001262388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 211043888
MAIL ADDRESS:
STREET 1: 450 LEXINGTON AVENUE, FLOOR 13
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER NAME:
FORMER CONFORMED NAME: Greene-Sulzberger Gabrielle
DATE OF NAME CHANGE: 20141030
FORMER NAME:
FORMER CONFORMED NAME: GREENE GABRIELLE E
DATE OF NAME CHANGE: 20030904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-24
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001262388
Sulzberger Gabrielle
C/O CEREVEL THERAPEUTICS HOLDINGS, INC.
222 JACOBS STREET, SUITE 200
CAMBRIDGE
MA
02141
1
0
0
0
Common Stock
2021-06-24
4
M
0
14270
A
49624
D
Restricted Stock Units
2021-06-24
4
M
0
14270
0.00
D
Common Stock
14270
14270
D
The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
14,270 RSUs vested on June 24, 2021, the second anniversary of the vesting commencement date of June 24, 2019 (the "Vesting Commencement Date"), with the remainder vesting on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service relationship with the Issuer through each such date.
/s/ Mark Bodenrader, as Attorney-in-Fact
2021-06-24